Trinity Biotech to Present at Sidoti & Company's Semiannual New York Micro-Cap Conference on January 9, 2012
DUBLIN, Jan. 4, 2012 /PRNewswire/ -- Trinity Biotech plc (NasdaqGS: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, announced today that the Company will present at the Sidoti & Company's Semiannual New York Micro-Cap Conference on Monday, January 9, 2012 at 9:20 a.m. ET. The conference will be held at the Grand Hyatt New York Hotel in New York City.
About Trinity Biotech plc
Trinity Biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States, Germany, France and the U.K. and through a network of international distributors and strategic partners in over 75 countries worldwide. For further information please see the Company's website: www.trinitybiotech.com.
Contact: Trinity Biotech plcLytham Partners LLC
Joe Diaz, Joe Dorame & Robert Blum